AAAAAA

   
Results: 1-25 | 26-31 |
Results: 26-31/31
RISK-FACTORS FOR KAPOSIS-SARCOMA IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE
Authors: GALLANT JE MOORE RD RICHMAN DD KERULY J CHAISSON RE BARTLETT J MCAVINUE S BRYSON Y COHEN H FISCHL M BOLIN T BURROUGH Y MILDVAN D FOX A RICHMAN D FREEMAN B SIMON G GRABOWY KW CHERNOFF D DUFF P THOMPSON S BARRETT K AWE R LEONARD S TURNER P HAWKINS M MURRAY H BOWERS J TILSON H SMILEY L
Citation: Je. Gallant et al., RISK-FACTORS FOR KAPOSIS-SARCOMA IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE, Archives of internal medicine, 154(5), 1994, pp. 566-572
PRECLINICAL IMMUNOGENICITY STUDIES IN BABOONS WITH CANDIDATE HIV-1 SUBUNIT VACCINES PREDICT THE HUMAN IMMUNE-RESPONSE
Authors: STEIMER K BAENZIGER J KAHN J VANNEST G CHERNOFF D DEKKER C SINANGIL F
Citation: K. Steimer et al., PRECLINICAL IMMUNOGENICITY STUDIES IN BABOONS WITH CANDIDATE HIV-1 SUBUNIT VACCINES PREDICT THE HUMAN IMMUNE-RESPONSE, AIDS research and human retroviruses, 9, 1993, pp. 190000041-190000041
PHASE-1 DOSE-ESCALATION MTP-PE STUDY OF AN HIV-1 GP120 VACCINE IN SERONEGATIVE ADULTS
Authors: KAHN J CHERNOFF D SINANGIL F MURCAR N WYNNE D COLEMAN R STEIMER K DEKKER C
Citation: J. Kahn et al., PHASE-1 DOSE-ESCALATION MTP-PE STUDY OF AN HIV-1 GP120 VACCINE IN SERONEGATIVE ADULTS, AIDS research and human retroviruses, 9, 1993, pp. 190000112-190000112
PHASE-STUDY OF AN HIV-1 GP 120 VACCINE COMBINED WITH THE NOVEL ADJUVANT EMULSION, MF59 AND THE BIOLOGIC RESPONSE MODIFIER MTP-PE IN HIV SERONEGATIVE ADULTS
Authors: KAHN J CHERNOFF D SINANGIL F BAENZIGER J MURCAR N WYNNE D COLEMAN R STEIMER K DEKKER C
Citation: J. Kahn et al., PHASE-STUDY OF AN HIV-1 GP 120 VACCINE COMBINED WITH THE NOVEL ADJUVANT EMULSION, MF59 AND THE BIOLOGIC RESPONSE MODIFIER MTP-PE IN HIV SERONEGATIVE ADULTS, Journal of cellular biochemistry, 1993, pp. 79-79
MAPPING OF ANTIBODY-RESPONSES OF HIV-1 SERONEGATIVE INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-SF2 GP120
Authors: SINANGIL F TRIBBICK G MASON T KAHN J CHERNOFF D STEIMER K
Citation: F. Sinangil et al., MAPPING OF ANTIBODY-RESPONSES OF HIV-1 SERONEGATIVE INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-SF2 GP120, Journal of cellular biochemistry, 1993, pp. 86-86
THE PREVALENCE OF HEPATITIS-C VIRUS (HCV) IN PATIENTS WITH HUMORAL IMMUNODEFICIENCY RECEIVING INTRAVENOUS IMMUNOGLOBULIN (IVIG)
Authors: ADELMAN D WILBER J CHAN C URDEA M CHERNOFF D
Citation: D. Adelman et al., THE PREVALENCE OF HEPATITIS-C VIRUS (HCV) IN PATIENTS WITH HUMORAL IMMUNODEFICIENCY RECEIVING INTRAVENOUS IMMUNOGLOBULIN (IVIG), The Journal of immunology, 150(8), 1993, pp. 163-163
Risultati: 1-25 | 26-31 |